Japan Cardiac Surgery Instruments Market: Industry Analysis and Forecast (2024-2030)

The Japan Cardiac Surgery Instruments Market size was valued at USD 138.16 Million in 2023 and the total Japan Cardiac Surgery Instruments revenue is expected to grow at a CAGR of 8.1% from 2023 to 2030, reaching nearly USD 238.32 Million in 2030.
Japan Cardiac Surgery Instruments Market Overview
The Japan Cardiac Surgery Instruments Market report provides a thorough examination of Japan's landscape within the japan cardiac surgery instruments sector. By diving into market dynamics, influential trends, and factors driving the demand and advancement of cardiac surgical instruments, the report offers a comprehensive analysis. Drawing insights from diverse and reliable sources, including industry reports, governmental databases, healthcare entities, and validated market studies, the findings ensure accuracy and credibility. Within the context, the report outlines the promising growth prospects observed in the Japan Cardiac Surgery Instruments Market. It meticulously examines the current market scenario, explaining the pivotal drivers, limitations, opportunities, and challenges that shape the market's dynamics. Additionally, the report delves into Japan's cardiac surgery landscape, providing a detailed analysis of prevalent surgical practices, technological strides, and the adoption of cutting-edge cardiac surgery instruments.

To know about the Research Methodology :- Request Free Sample Report

The comprehensive overview encapsulates the evolving trends, procedural insights, and the increasing demand for innovative instruments within Japan's healthcare system.



Year
CR-Certified Hospitals (%)
Inpatient CR Participation (%)
Outpatient CR Participation (%)
Continued CR after Discharge (%)


2018
59.2
41.5
2.8
5.0


2019
61.0
43.2
3.1
4.8


2020
62.5
45.1
3.3
4.7


2021
64.0
46.8
3.5
4.6


2022
65.6
48.5
3.7
4.5


2023
67.2
50.2
3.9
4.4



Japan Cardiac Surgery Instruments Market Dynamics:
Cardiac Rehabilitation Trends in Japan: Factors Influencing Patient Participation

The comprehensive MMR study utilizing various health databases sheds light on trends and factors influencing cardiac rehabilitation (CR) participation across major cardiovascular conditions in Japan. The analysis of acute heart failure (AHF), acute coronary syndrome (ACS), acute aortic dissection (AAD), peripheral artery disease (PAD), and post-cardiovascular surgery cases revealed a consistent increase in the number of patients undergoing CR. However, outpatient CR rates remained notably lower compared to inpatient participation, especially for AHF (3.5%), AAD (3.2%), and PAD (1.7%) cases. Factors such as age, gender, BMI, comorbidities, and institutional capacity significantly influenced CR engagement in both inpatient and outpatient settings. Additionally, higher age, multiple comorbidities, and limited institutional resources contributed to lower outpatient CR rates. These findings offer crucial insights for cardiologists to strategize and improve CR participation, particularly in outpatient settings, aiming for more inclusive and effective cardiac rehabilitation programs in Japan.

Population Age Structure in Japan:-




2022
 2030(Projection)


Country
0-14 Years Old
15-64 Years Old
65 Years old And Over
0-14 Years Old
15-64Years Old
65 Years old And Over


Japan
11.9
59.5
28.6
10.2
51.6
38.1



Advancing Cardiac Surgery Quality: Insights and Challenges from Japan's Database-driven Risk Models
Japan Adult Cardiovascular Surgery Database (JACVSD) has proven instrumental in refining risk models for cardiac valve procedures, offering valuable insights into surgical outcomes. With 6562 valve procedure records analysed across 97 sites in Japan, the comprehensive dataset, comprising 255 variables, facilitated the construction of a robust statistical model using multiple logistic regression. Additionally, the observed 30-day and operative mortality rates stood at 2.9% and 4.0%, respectively, with emergent or salvage status, reoperation, and left ventricular dysfunction emerging as significant variables with high odds ratios. The model's performance, evaluated using the Hosmer-Lemeshow (H-L) test and C-index, demonstrated commendable accuracy, with a C-index of 0.80 for 30-day mortality. The data-driven approach from Japan exhibits outcomes on par with global benchmarks, aligning closely with the performance of esteemed international cardiac surgery databases. However, maintaining accurate, location-specific databases remains crucial to enhancing surgical quality, presenting both a challenge and an opportunity for Japan's cardiac surgery instruments market to continually improve by integrating precise local data for better risk assessment and surgical outcomes.
Japan Cardiac Surgery Instruments Market Segment Analysis:
Based on Application, the Coronary Artery Bypass Graft (CABG) segment held the largest market share of more than 45% and dominated the Japan Cardiac Surgery Instruments industry in 2023. The segment is further expected to grow at a CAGR of 8.3% and maintain its dominance during the forecast period. The rising demand is driven by factors such as increasing prevalence of coronary artery disease in japan, the aging population, and the growing adoption of minimally invasive CABG techniques has been expected to be the major factor driving the segment growth.



Besides that, the Heart Valve Surgery segment is expected to grow at a rapid CAGR and offer lucrative growth opportunities for Japan cardiac surgery instruments manufacturers all across Japan during the forecast period. The rising demand for valve replacement and repairs thanks to valve stenosis and regurgitation systems are expected to be the major factors driving the segment growth. The segment supports socioeconomic factors such as, rising healthcare spending, and improved healthcare infrastructure making more accessible and available in more regions.

The major key players in the Market are LivaNova, B. Braun, Medline Industries, and KLS Martin. Thus, increasing demand for the Japan Cardiac Surgery Instruments market supports the segment growth.
Japan Cardiac Surgery Instruments Market Scope: Inquire before buying



Japan Cardiac Surgery Instruments Market


Report Coverage
Details


Base Year:
2023
Forecast Period:
2024-2030


Historical Data:
2018 to 2023
Market Size in 2023:
US $ 138.16 Mn.


Forecast Period 2024 to 2030 CAGR:
8.1%
Market Size in 2030:
US $ 238.32 Mn.


 Segments Covered:
by Type
Forceps
Vascular Forceps
Grasping Forceps
Other Forceps
Needle Holders
Scissors
Clamps


by Application
Coronary Artery Bypass Graft (CABG)
Heart Valve Surgery
Paediatric Cardiac Surgery


by End User
Hospitals and Cardiac Centers
Ambulatory Surgery Centers



Japan Cardiac Surgery Instruments Market Key Players:
1. Terumo Corporation
2. Fukuda
3. LivaNova
4. B. Braun
5. Medline Industries
6. KLS Martin
7. STILLE
8. Nipro Corporation

1. What is the projected market size & and growth rate of the Market?
Ans. The Market size was valued at USD 138.16 Million in 2023 and the total Japan Cardiac Surgery Instruments revenue is expected to grow at a CAGR of 8.1% from 2023 to 2029, reaching nearly USD 238.32 Million.

2. What segments are covered in the Japan Cardiac Surgery Instruments Market report?
Ans. The segments covered in the Japan Cardiac Surgery Instruments Market report are type, application, and end-users.

3. What factors drive the growth of the Japan Cardiac Surgery Instruments market?
Ans. Factors such as aging population, increasing prevalence of cardiovascular diseases, adoption of minimally invasive procedures, and technological advancements are driving the growth of the Cardiac Surgery Instruments market in Japan.